MET and cancer: For example, tetraspanin CD82 is frequently down‐regulated in advanced stages of cancer, and overexpression of CD82 inhibits tumour migration and invasion via regulation of several signal pathways such as hepatocyte growth factor receptor (HGFR) pathway.11, 12